Marker Therapeutics (MRKR) EPS (Basic) (2010 - 2026)
Marker Therapeutics (MRKR) posted quarterly EPS (Basic) of -$0.22 for Q1 2026, up 48.51% year-over-year from -$0.15 in Q1 2025, and down 49.18% quarter-over-quarter from -$0.15 in Q4 2025.
Marker Therapeutics (MRKR) EPS (Basic) (2010 - 2026) Analysis & Trends
Marker Therapeutics (MRKR) has reported EPS (Basic) for 17 consecutive years, with -$0.22 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 48.51% year-over-year to -$0.22; the TTM figure through Mar 2026 stood at -$0.66 (up 51.07% YoY), while the FY2025 annual figure was -$0.63, up 47.41% from the prior year.
- EPS (Basic) declined to -$0.22 in Q1 2026 per MRKR's latest filing, from -$0.15 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.75 in Q2 2023 and bottomed at -$1.22 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.25 across 5 years, with a median of -$0.29 in 2024.
- Annual changes were most pronounced in 2023 — EPS (Basic) jumped 256.66% — and 2024, when it slumped 6392.32%.
- Marker Therapeutics' EPS (Basic) stood at -$0.1 in 2022, then soared by 92.66% to -$0.01 in 2023, then slumped by 6392.32% to -$0.46 in 2024, then soared by 67.87% to -$0.15 in 2025, then sank by 49.18% to -$0.22 in 2026.
- Business Quant data shows MRKR's EPS (Basic) at -$0.22 in Q1 2026, -$0.15 in Q4 2025, and -$0.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Marker Therapeutics | 23.95 Mn | 12.02 Mn | - | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.15 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.43 |
| Dec 31, 2024 | -0.46 |
| Sep 30, 2024 | -0.29 |
| Jun 30, 2024 | -0.38 |
| Mar 31, 2024 | -0.35 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | 0.75 |
| Mar 31, 2023 | -0.09 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -1.22 |
| Dec 31, 2021 | -1.49 |
| Sep 30, 2021 | -1.50 |
| Jun 30, 2021 | -3.23 |